ISLET CELL TRANSPLANT OFFERS NEW LIFE FOR 52-YEAR-OLD ACTOR FROM COLORADO

Last Halloween, Steph skipped the candy corn and instead went for 400,000 islet cells, injected into a vein near his liver. On Thanksgiving, Steph got not cranberries - but another 400,000 islet (rhymes with pilot) cells.

In December, just in time for Christmas, Steph got his final dose of islet cells. And suddenly, the insulin highs and sugar lows that have made his life a living hell for 23 years are nearly gone. "Holy gotchamoley!" said Steph, 52, an actor who lives in Parker Colorado. "It means the world; it means everything to me." Steph is apparently the first person in the Rocky Mountain region to receive an islet cell transplant, an experimental procedure aimed at bringing stability to diabetics who can't regulate their blood sugars. Because the procedure is experimental, Steph worries that his insurance carrier might drop him if they knew, so he requested that his last name not be used. Some 18 million people in the United States, 6.3 percent of the population, have diabetes, according to the American Diabetes Association. The annual economic cost of diabetes is $132 billion, or one of every 10 U.S. health care dollars, says the association.

 

Steph has Type 1 diabetes - his pancreas doesn't produce insulin, which is necessary for the body to use sugar to fuel its cells. Islet cells occur in clumps, like islands in a sea, and comprise just 1 percent of the cells in the pancreas. But they're the cells that tell the body when to produce and secrete insulin, so they are essential to well-being. The more common Type 2 diabetes usually begins in adulthood and has a strong link to obesity. With Type 2, either the body does not produce enough insulin or the cells ignore it. For most of the last 23 years, Steph has had to inject himself with insulin six or seven times a day, whenever his blood sugars were too high and he started feeling as if he were walking through quicksand. Often, he gave himself too much and he would get hyperactive, the signal that he needed to eat peanut butter, crackers, juice or potato chips - a combination of quick-acting and slow-acting sugars that brought him back into balance. Four years ago, Steph got an insulin pump. Instead of preparing a needle several times a day, he only had to push a button on the pump whenever he felt the need for insulin. But he still couldn't control the highs and lows. Sometimes he just didn't want to give himself the insulin he knew he needed. He's had car accidents in the past that he says were the result of hitting a high behind the wheel. The danger he posed to himself and others made him an ideal candidate for islet cells, said Dr. Alexander Wiseman, a transplant physician at University of Colorado Hospital.

 

The first islet cell transplant was done four years ago in Edmonton, Alberta Canada. A study of 36 islet cell recipients found that 19 remained insulin independent a year after the procedure, said Dr. James Shapiro, director of the program in Edmonton. Of the 17 who still need insulin, seven of those have derived some benefit and improvement in quality of life. A whole pancreas transplant is another option, but the pancreas is a fragile organ, and typically just 10 percent are suitable, he said. So, Steph got on the list for islet cell transplant. "I got the call in the middle of the night on Halloween eve," Dr. Wiseman recalled. An organ donor had just died and his pancreas couldn't be used, but might be suitable for harvesting islet cells. A five person team that is on call 365 days a year sprung into action, injecting the pancreas with a collagenase to break it down. It took them seven hours to harvest the islet cells from the pancreas and get them into a small sterile tube. With the help of diabetes specialist Dr. Peter Gottleib, an interventional radiologist, and a team of nurses, DR.Wiseman prepared Steph for the procedure. A needle poked through the skin in Steph's abdomen and went into a vessel next to his liver. A catheter slid in, the needle came out, and the islet cells dripped in from an IV bag.

When it was over, a Band Aid protected the BB-sized incision. The second opportunity to harvest and inject came on Thanksgiving Day, and the third came last month. Steph will have to take anti rejection medication the rest of his life, which will leave him more vulnerable to infections and can cause mouth ulcers, high blood pressure, high cholesterol and gastro- intestinal problems. But so far, "we've seen zero side effects in Steph," Dr. Wiseman said. He was back on the insulin pump for a couple of weeks to give the islets a rest. After that, however, they should be ready for full action on their own.

For diabetics who have good control over their blood sugars, islet cell transplants probably aren't worth the trade-offs, Dr. Wiseman said. Still, the waiting list for the transplant is growing weekly, he said. "We'll never have enough cadavers to meet demand," he said. For his part, Steph hopes he has seen the last of the days when, once or twice a day he'd slow to a crawl and couldn't raise his arms until he got another dose of insulin. "I'll be able to drive anywhere and not have to worry about it now," he said. "This means everything." .

Source diabetesnews